Jane Street’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
24,900
+9,800
+65% +$130K ﹤0.01% 8768
2026
Q1
$208K Buy
+15,100
New +$228K ﹤0.01% 10055
2025
Q4
Sell
-26,600
Closed -$493K 11244
2025
Q3
$493K Buy
+26,600
New +$418K ﹤0.01% 7891
2025
Q1
Sell
-23,600
Closed -$520K 9548
2024
Q4
$520K Sell
23,600
-17,200
-42% -$331K ﹤0.01% 6701
2024
Q3
$687K Buy
+40,800
New +$605K ﹤0.01% 6624

Other funds holding CLBT

Jane Street's CLBT Position: Q2 2026 in Review

Jane Street sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 714,514 shares — an estimated $9.44M sold.

Jane Street first reported a position in CLBT in Q1 2024 and held it in 7 quarters. The position peaked at $9.85M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jane Street reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 714,514 Cellebrite shares in Q2 2026, an estimated $9.44M.
  • Jane Street first reported a position in Cellebrite in Q1 2024 and held it in 7 quarters.
  • Jane Street's Cellebrite position peaked at $9.85M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.